1n2r

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
==Overview==
==Overview==
-
HLA-B*4402 and B*4403 are naturally occurring MHC class I alleles that are, both found at a high frequency in all human populations, and yet they only, differ by one residue on the alpha2 helix (B*4402 Asp156-->B*4403 Leu156)., CTLs discriminate between HLA-B*4402 and B*4403, and these allotypes, stimulate strong mutual allogeneic responses reflecting their known, barrier to hemopoeitic stem cell transplantation. Although HLA-B*4402 and, B*4403 share >95% of their peptide repertoire, B*4403 presents more unique, peptides than B*4402, consistent with the stronger T cell alloreactivity, observed toward B*4403 compared with B*4402. Crystal structures of B*4402, and B*4403 show how the polymorphism at position 156 is completely buried, and yet alters both the peptide and the heavy chain conformation, relaxing, ligand selection by B*4403 compared with B*4402. Thus, the polymorphism, between HLA-B*4402 and B*4403 modifies both peptide repertoire and T cell, recognition, and is reflected in the paradoxically powerful alloreactivity, that occurs across this "minimal" mismatch. The findings suggest that, these closely related class I genes are maintained in diverse human, populations through their differential impact on the selection of peptide, ligands and the T cell repertoire.
+
HLA-B*4402 and B*4403 are naturally occurring MHC class I alleles that are both found at a high frequency in all human populations, and yet they only differ by one residue on the alpha2 helix (B*4402 Asp156-->B*4403 Leu156). CTLs discriminate between HLA-B*4402 and B*4403, and these allotypes stimulate strong mutual allogeneic responses reflecting their known barrier to hemopoeitic stem cell transplantation. Although HLA-B*4402 and B*4403 share >95% of their peptide repertoire, B*4403 presents more unique peptides than B*4402, consistent with the stronger T cell alloreactivity observed toward B*4403 compared with B*4402. Crystal structures of B*4402 and B*4403 show how the polymorphism at position 156 is completely buried and yet alters both the peptide and the heavy chain conformation, relaxing ligand selection by B*4403 compared with B*4402. Thus, the polymorphism between HLA-B*4402 and B*4403 modifies both peptide repertoire and T cell recognition, and is reflected in the paradoxically powerful alloreactivity that occurs across this "minimal" mismatch. The findings suggest that these closely related class I genes are maintained in diverse human populations through their differential impact on the selection of peptide ligands and the T cell repertoire.
==Disease==
==Disease==
Line 16: Line 16:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Protein complex]]
[[Category: Protein complex]]
-
[[Category: Brooks, A.G.]]
+
[[Category: Brooks, A G.]]
-
[[Category: Clements, C.S.]]
+
[[Category: Clements, C S.]]
-
[[Category: Ely, L.K.]]
+
[[Category: Ely, L K.]]
-
[[Category: Gorman, J.J.]]
+
[[Category: Gorman, J J.]]
[[Category: Kjer-Nielsen, L.]]
[[Category: Kjer-Nielsen, L.]]
-
[[Category: Koelle, D.M.]]
+
[[Category: Koelle, D M.]]
-
[[Category: Lovrecz, G.O.]]
+
[[Category: Lovrecz, G O.]]
[[Category: Lu, L.]]
[[Category: Lu, L.]]
-
[[Category: Macdonald, W.A.]]
+
[[Category: Macdonald, W A.]]
[[Category: McCluskey, J.]]
[[Category: McCluskey, J.]]
[[Category: Mifsud, N.]]
[[Category: Mifsud, N.]]
-
[[Category: Purcell, A.W.]]
+
[[Category: Purcell, A W.]]
[[Category: Rossjohn, J.]]
[[Category: Rossjohn, J.]]
-
[[Category: Williams, D.S.]]
+
[[Category: Williams, D S.]]
[[Category: ACY]]
[[Category: ACY]]
[[Category: immune system]]
[[Category: immune system]]
Line 35: Line 35:
[[Category: signal]]
[[Category: signal]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 16:26:49 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:01:42 2008''

Revision as of 12:01, 21 February 2008


1n2r, resolution 1.7Å

Drag the structure with the mouse to rotate

A natural selected dimorphism in HLA B*44 alters self, peptide reportoire and T cell recognition.

Contents

Overview

HLA-B*4402 and B*4403 are naturally occurring MHC class I alleles that are both found at a high frequency in all human populations, and yet they only differ by one residue on the alpha2 helix (B*4402 Asp156-->B*4403 Leu156). CTLs discriminate between HLA-B*4402 and B*4403, and these allotypes stimulate strong mutual allogeneic responses reflecting their known barrier to hemopoeitic stem cell transplantation. Although HLA-B*4402 and B*4403 share >95% of their peptide repertoire, B*4403 presents more unique peptides than B*4402, consistent with the stronger T cell alloreactivity observed toward B*4403 compared with B*4402. Crystal structures of B*4402 and B*4403 show how the polymorphism at position 156 is completely buried and yet alters both the peptide and the heavy chain conformation, relaxing ligand selection by B*4403 compared with B*4402. Thus, the polymorphism between HLA-B*4402 and B*4403 modifies both peptide repertoire and T cell recognition, and is reflected in the paradoxically powerful alloreactivity that occurs across this "minimal" mismatch. The findings suggest that these closely related class I genes are maintained in diverse human populations through their differential impact on the selection of peptide ligands and the T cell repertoire.

Disease

Known diseases associated with this structure: Abacavir hypersensitivity, susceptibility to OMIM:[142830], Hypoproteinemia, hypercatabolic OMIM:[109700], Spondyloarthropathy, susceptibility to, 1 OMIM:[142830], Stevens-Johnson syndrome, carbamazepine-induced, susceptibility to OMIM:[142830]

About this Structure

1N2R is a Protein complex structure of sequences from Homo sapiens with as ligand. Full crystallographic information is available from OCA.

Reference

A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition., Macdonald WA, Purcell AW, Mifsud NA, Ely LK, Williams DS, Chang L, Gorman JJ, Clements CS, Kjer-Nielsen L, Koelle DM, Burrows SR, Tait BD, Holdsworth R, Brooks AG, Lovrecz GO, Lu L, Rossjohn J, McCluskey J, J Exp Med. 2003 Sep 1;198(5):679-91. Epub 2003 Aug 25. PMID:12939341

Page seeded by OCA on Thu Feb 21 14:01:42 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools